A.F. Khalirakhmanov1,2, E.A. Gaziev2, S.V. Zinchenko1,2, N.I. Bariev1, A.Z. Sharafeev2, I.V. Ryabchikov1
1Kazan Federal University, Kazan
2University Hospital, Medical part of Kazan Federal University, Kazan
Khalirakhmanov A.F. — PhD, Doctor of the Department of X-ray diagnostic methods and treatment of University Hospital, Medical part of Kazan Federal University
1a Chekhov Str., Kazan, Russian Federation, 420043, e-mail: ai.bolit@mail.ru
Abstract. Breakthrough in oncology over the last years improved oncology patient’s survival. This was achieved through the early diagnosis and effective treatment by modern chemotherapeutic agents. However, new challenges have emerged. Patients may experience adverse cardiovascular events related to their oncology treatment or as a result of an exacerbation of underlying cardiovascular disease. The article describes the various pathophysiological aspects of chemotherapy treatment and radiotherapy that impact on the onset and progression of cardiovascular diseases.
Key words: cardio-oncology, coronary heart disease, cardiotoxicity, chemotherapy, radiotherapy.